Pricing Log in Create free account

Soligenix Inc. (SNGX) vs Exicure, Inc. (XCUR)

Soligenix Inc. and Exicure, Inc. are both Biotechnology companies. Soligenix Inc. and Exicure, Inc. are of similar size ($7.7M and $7.3M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against −50.4%. Across the 13 metrics below, Exicure, Inc. leads on 9 and Soligenix Inc. on 4.

Valuation

Metric SNGX XCUR Biotechnology median
P/E n/m n/m 8.50
P/S 11.29 0.26 9.71
P/B 0.84 7.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 n/m 0.64
EV/Sales (3.73) 0.24 9.21
Earnings yield (211.20%) (118.92%) (33.15%)
Free cash flow yield (174.60%) (84.13%) (25.50%)

Profitability

Metric SNGX XCUR Biotechnology median
Gross margin 0.00% 80.08% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (241.65%) (168.37%) (56.36%)
Return on assets (125.95%) (54.98%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SNGX XCUR Biotechnology median
Revenue growth (TTM) (50.37%) 2,366.45% 6.02%
EPS growth (last fiscal year) 57.03% 83.37% 30.26%
Revenue growth, 5-year CAGR (51.88%) 33.48% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SNGX XCUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.77 0.56 4.72
Net debt to EBITDA 0.67 0.99 0.96

Dividend

Metric SNGX XCUR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SNGX XCUR Biotechnology median
Market cap 7.73m 7.33m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack